BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 18975359)

  • 1. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.
    Kozora E; Arciniegas DB; Filley CM; West SG; Brown M; Miller D; Grimm A; Devore MD; Wingrove C; Zhang L
    Arthritis Rheum; 2008 Nov; 59(11):1639-46. PubMed ID: 18975359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery.
    Kozora E; Ellison MC; West S
    Arthritis Rheum; 2006 Aug; 55(4):628-35. PubMed ID: 16874786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus.
    Filley CM; Kozora E; Brown MS; Miller DE; West SG; Arciniegas DB; Grimm A; Zhang L
    Cogn Behav Neurol; 2009 Mar; 22(1):38-44. PubMed ID: 19372769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do subjective cognitive complaints correlate with cognitive impairment in systemic lupus erythematosus? A Danish outpatient study.
    Vogel A; Bhattacharya S; Larsen JL; Jacobsen S
    Lupus; 2011 Jan; 20(1):35-43. PubMed ID: 21233148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
    Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations.
    Kozora E; Filley CM; Zhang L; Brown MS; Miller DE; Arciniegas DB; Pelzman JL; West SG
    Lupus; 2012 Apr; 21(4):402-11. PubMed ID: 22170761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive function in a systemic lupus erythematosus inception cohort.
    Petri M; Naqibuddin M; Carson KA; Sampedro M; Wallace DJ; Weisman MH; Holliday SL; Padilla PA; Brey RL
    J Rheumatol; 2008 Sep; 35(9):1776-81. PubMed ID: 18634154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus.
    Glanz BI; Slonim D; Urowitz MB; Gladman DD; Gough J; MacKinnon A
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Oct; 10(4):232-8. PubMed ID: 9359119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are cognitive and olfactory dysfunctions in neuropsychiatric lupus erythematosus dependent on anxiety or depression?
    Cavaco S; Martins da Silva A; Santos E; Coutinho E; Marinho A; Moreira I; Gonçalves A; Pinto C; Teixeira-Pinto A; Vasconcelos C
    J Rheumatol; 2012 Apr; 39(4):770-6. PubMed ID: 22382338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognitive dysfunction.
    Emmer BJ; Steup-Beekman GM; Steens SC; Huizinga TW; van Buchem MA; van der Grond J
    Arthritis Rheum; 2008 May; 58(5):1451-7. PubMed ID: 18438847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging.
    Bosma GP; Rood MJ; Zwinderman AH; Huizinga TW; van Buchem MA
    Arthritis Rheum; 2000 Jan; 43(1):48-54. PubMed ID: 10643699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus.
    Roebuck-Spencer TM; Yarboro C; Nowak M; Takada K; Jacobs G; Lapteva L; Weickert T; Volpe B; Diamond B; Illei G; Bleiberg J
    Arthritis Rheum; 2006 Jun; 55(3):434-41. PubMed ID: 16739211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
    Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
    Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive dysfunction in systemic lupus erythematosus.
    Emori A; Matsushima E; Aihara O; Ohta K; Koike R; Miyasaka N; Kato M
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):584-9. PubMed ID: 16194262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Hanly JG; Fisk JD; McCurdy G; Fougere L; Douglas JA
    J Rheumatol; 2005 Aug; 32(8):1459-6. PubMed ID: 16078320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study.
    Appenzeller S; Cendes F; Costallat LT
    Arthritis Rheum; 2009 May; 61(5):680-7. PubMed ID: 19405004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
    Yoshio T; Hirata D; Onda K; Nara H; Minota S
    J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
    Hanly JG; Robichaud J; Fisk JD
    J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in patients with systemic lupus erythematosus.
    Hanly JG; Fisk JD; Sherwood G; Jones E; Jones JV; Eastwood B
    J Rheumatol; 1992 Apr; 19(4):562-7. PubMed ID: 1593578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.